Superworth

Savara EPS SVRA

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$0.58
Latest quarter, Q2 FY26
−$0.16
Fiscal year 2025
−$0.53

Savara's earnings per share was −$0.58 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.16.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.53n/a
FY2024−$0.47n/a
FY2023−$0.32n/a
FY2022−$0.25n/a
FY2021−$0.34n/a
FY2020−$0.84n/a
FY2019−$1.93n/a
FY2018−$1.88n/a
FY2017−$3.06n/a
FY2016−$8.98n/a
FY2015−$16.80n/a
FY2014−$16.10n/a
FY2013−$22.40n/a
FY2012−$23.10n/a
FY2011−$34.30n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.16n/a−$0.58
Q1 FY26−$0.15n/a−$0.56
Q4 FY25−$0.13n/a−$0.53
Q3 FY25−$0.14n/a−$0.53
Q2 FY25−$0.14n/a−$0.50
Q1 FY25−$0.12n/a−$0.48
Q4 FY24−$0.13n/a−$0.47
Q3 FY24−$0.11n/a−$0.42
Q2 FY24−$0.12n/a−$0.41
Q1 FY24−$0.11n/a−$0.36
Q4 FY23−$0.08n/a−$0.32
Q3 FY23−$0.10n/a−$0.31

Against its peers

Companies in Drug Manufacturers - General nearest Savara's size, closest first, today.

CompanyEPS, 12 monthsGrowth
SVRASavara−$0.58
ABUSArbutus Biopharma$0.78
COLLCollegium Pharmaceutical$1.24+19% a year
AMPHAmphastar Pharmaceuticals$1.70−36% a year
OMEROmeros$1.52
CRMDCorMedix$2.13+184% a year
ZVRAZevra Therapeutics$0.93
IRWDIronwood Pharmaceuticals$0.77
PBYIPuma Biotechnology$0.52−47% a year
PCRXPacira BioSciences$0.35
ANABAnaptysbio$4.57
Peer median$1.08

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Savara

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.